Theriva Biologics Inc (AMEX: TOVX) is -88.00% lower on its value in year-to-date trading and has touched a low of $1.22 and a high of $17.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TOVX stock was last observed hovering at around $1.34 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $1.29, the stock is -9.66% and -15.00% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.77 million and changing -3.73% at the moment leaves the stock -79.25% off its SMA200. TOVX registered -91.58% loss for a year compared to 6-month loss of -80.71%. The firm has a 50-day simple moving average (SMA 50) of $1.5394 and a 200-day simple moving average (SMA200) of $6.27395.
The stock witnessed a -34.52% gain in the last 1 month and extending the period to 3 months gives it a -70.48%, and is -3.73% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.61% over the week and 9.10% over the month.
Theriva Biologics Inc (TOVX) has around 22 employees, a market worth around $3.59M and $0.00M in sales. Distance from 52-week low is 5.74% and -92.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-103.59%).
The EPS is expected to grow by 15.40% this year
21.0 institutions hold shares in Theriva Biologics Inc (TOVX), with institutional investors hold 23.69% of the company’s shares. The shares outstanding are 2.78M, and float is at 2.75M with Short Float at 3.76%. Institutions hold 21.21% of the Float.
